Project

Characterization of MAGED1 as a negative regulator of NOD1/2 immunity

Duration
01 January 2016 → 31 December 2019
Funding
Research Foundation - Flanders (FWO)
Research disciplines
  • Natural sciences
    • Biochemistry and metabolism
    • Systems biology
  • Medical and health sciences
    • Medical biochemistry and metabolism
    • Morphological sciences
    • Medical biochemistry and metabolism
    • Morphological sciences
    • Medical biochemistry and metabolism
    • Morphological sciences
Keywords
signaling NOD receptor ubiquitylation Melanoma antigen
 
Project description

NOD1/2 signaling is strongly regulated by the ubiquitylation of the main adaptor protein RIPK2. MAGED1 binds with several E3 ubiquitin ligases known to ubiquitylate RIPK2. We believe that MAGED1 affects the stability of RIPK2 by regulating its ubiquitylation status. MAGED1 could therefore emerge as a novel negative regulator of NOD1/2 signaling.